| Customization: | Available |
|---|---|
| Certification: | ISO, FDA, Halal, Kosher |
| Assay Method: | HPLC |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Nefiracetam is a hydrophobic derivative of Piracetam and all Raceam compounds are synthesized by Piracetam. Nefiracetam is mainly produced by Daiichi Sankyo (a Japanese pharmaceutical company) for the treatment of Alzheimer's disease. Except for all mechanisms attributable to nefiracetam, it is generally considered a substance, the discovery of calcium channels in the body, and the indirect transfer of stimulating signal substances, as a partial agonist of the glycine binding site of the NDMA receptor.
|
Product Name
|
Pharmaceutical intermediate 77191-36-7 Nefiracetam |
|
CAS No
|
77191-36-7 |
|
Specification
|
99% |
|
Appearance
|
white powder
|
|
Grade
|
food,cosmetic pharm grade
|
|
Test Method
|
HPLC
|
|
Shelf Life
|
2 Years
|
Nefiracetam is used to treat cerebrovascular diseases. It can enhance cognitive ability and prevent learning and memory damage by acting on the cerebral cortex. It does not have the characteristics of muscarinic receptor agonists and antagonists, nor does it inhibit the activity of acetylcholinease, so it is anti-forgetting and enhancing The effect of memory is to increase the release of acetylcholine in the cerebral cortex.
| Product name | CAS | Product name | CAS |
| Tianeptine | 30123-17-2 | Noopept | 157115-85-0 |
| Alpha GPC | 28319-77-9 | Sunifiram | 314728-85-3 |
| Coluracetam | 135463-81-9 | Aniracetam | 72432-10-1 |
| PRL-8-53 | 51352-87-5 | Oxiracetam | "68252-28-8 62613-82-5" |
| phenibute | 1078-21-3 | IDRA 21 | 22503-72-6 |
| Fasoracetam | 110958-19-5 | NSI189 | 1270138-40-3 |
| Sulbutamine | 3286-46-2 | NSI189 Phosphate | 1270138-41-4 |
| CDP Choline/Citicoline | 33818-15-4 | Vinpocetine | 42971-09-5 |
){kind=link}